期刊文献+

胰高血糖素样肽-1类似物对人成骨细胞Wnt信号通路相关基因表达的影响 被引量:7

Effect of glucagon like peptide-1 analogues on gene expression of Wnt signaling pathway-related factors in human osteoblasts
下载PDF
导出
摘要 目的观察胰高血糖素样肽-1类似物(利拉鲁肽)对人成骨细胞增殖及Wnt信号通路相关因子mRNA的表达,探讨胰高血糖素样肽-1(GLP-1)与骨代谢的关系。方法向体外培养的人成骨细胞中分别加入浓度为0 mol/L、10-7 mol/L、10-8mol/L、10-9 mol/L的GLP-1类似物,24 h后采用Cell Counting Kit-8(CCK-8)比色法检测成骨细胞增殖率,实时荧光定量PCR(Real-time RT-PCR)法检测Wnt-3a、LRP-5、β-catenin mRNA的表达。结果 (1)GLP-1促进人成骨细胞增殖(P<0.05),随着给药浓度的增高,成骨细胞增殖率下降(P<0.05);(2)低浓度GLP-1(10-9mol/L)上调人成骨细胞中Wnt-3a、LRP-5、β-catenin mRNA的表达(P<0.05);高浓度GLP-1(10-7mol/L、10-8mol/L)下调人成骨细胞中Wnt-3a、LRP-5、β-catenin mRNA的表达(P<0.05)。结论 GLP-1促进人成骨细胞的增殖,低浓度时Wnt信号通路可能参与了该调控过程,高浓度抑制Wnt信号通路相关基因的表达。 Objective To investigate the effect of glucagon like peptide-1 (GLP-1) analogues (Liraglutide) on the proliferation of the human osteoblasts and the mRNA expression of Wnt signaling pathway-related factors, and to explore the relationship between GLP-1 and bone metabolism. Methods The different concentrations of GLP-1 analogues (0 mol/L, 10-7 mol/L, 10-8 moL/L, and 10-9 mol/L) were additioned to human osteoblast culture in vitro. Cell proliferation was determined using cell counting kit-8 (CCK-8) after 24 h. The mRNA expression levels of Wnt-3a, LRP-5, and β-catenin were detected using real time polymerase chain reaction (Real-time RT-PCR). Results GLP-1 could promote the proliferation of human osteoblasts (P 〈 0. 05 ), while the proliferation rate of osteoblasts declined along with the concentration increase (P 〈 0.05). Low concentration of GLP-1 ( 10-9 mol/L) could up-regulate the mRNA expression levels of Wnt-3a, LRP-5, and [3-catenin in human osteoblasts ( P 〈 0. 05 ). In contrast, high concentrations of GLP-1 (10-7 mol/L and 10-8 mol/L) could down-regulate the mRNA expression levels of Wnt-3a, LRP-5, and [3-catenin in human osteoblasts (P 〈 0.05). Conclusion GLP-1 can promote the proliferation of human osteoblasts. When at low concentrations, Wnt signaling pathway may be involved in the regulatory process, while at high concentrations, it may inhibit the expression of Wnt signaling pathway-related genes.
作者 王婷 董进
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2013年第6期580-583,共4页 Chinese Journal of Osteoporosis
关键词 胰高血糖素样肽-1(GLP-1) 成骨细胞 增殖 WNT信号通路 Glucagon-like peptide-1 ( GLP-1 ) Osteoblasts Proliferation Wnt signaling pathway
  • 相关文献

参考文献1

二级参考文献20

  • 1Drucker DJ.Glocagon-like pepetide-1 and the islet beta-cell:augmentation of cell proliferation and inhibition of apoptosis[J].Endocrionology,2003,144(12):5145-5148.
  • 2Grieve DJ,Cassidy RS,Green BD.Emerging cardiocascular actions of the incretin hormone glucagon-like peptide-1:potential therapeutic benefits beyond glycaemic control?[J].Br J Pharmacol,2009,157(8):1340-1351.
  • 3Nystrom T,Gutniak MK,Zhang Q,et al.Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patiens with stable coronary artery disease[J].Am J Phsiol Endocrinol Metab,2004,287(6):E1209-E1215.
  • 4Nikolaidis LA,Doverspike A,Hentosz T,et al.Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines[J].Pharm Exp Ther,2005,312(1):303-308.
  • 5Aronne LJ,Thornton-Jones ZD.New targets for obesity pharmacotherapy[J].Clin Pharmacol Ther,2007,81(5):748-752.
  • 6Ducker DJ,Buse JB,Taylor K,et al.Exenatide once weekly versus twice dialy for the treatment of type 2 diabetes:a randomised,open-label,non-inferiority study[J].Lancet,2008,372(9645):1240-1250.
  • 7Amori RE,Lau J,Pittas AG.Effcacy and safety of incretin therapy in type 2 diabetes:systemic review and meta-analysis[J].JAMA,2007,298(2):194-206.
  • 8DeFronzo RA,Ratner RE,Han J,et al.Effect of exeratide(exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes[J].Diabetes Care,2005,28(5):1092-1100.
  • 9Bunck MC,Diamant M,Corner A,et al.One-year treatment with exenatide improves beta-cell funtion,compared with insulin glargine,in metformin-treated type 2 diabetes patients:a randomized,controled trail[J].Diabetes Care,2009,32(5):762-768.
  • 10Klonoff DC,Buse JB,Nielsen LL,et al.Exenatide effects on diabetes,obesity,cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for 3 year[J].Curr Med Res Opin,2008,24(1):275-286.

共引文献4

同被引文献85

  • 1环奕.WNT信号通路与肿瘤[J].基础医学与临床,2006,26(8):922-925. 被引量:17
  • 2肖元元, 徐淼, 刘若冰,等. 肝细胞脂肪性病变对胰高血糖素样肽1受体表达的影响[J]. 中华临床医师杂志(电子版), 2013,7(22):10118-10123.
  • 3Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 di- abetes[ J]. JAMA,2011,305 (21) :2184-2192.
  • 4Leslie WD, Rubin MR, Schwartz AV, et al. Type 2 diabetes and bone[ J]. J Bone Miner Res, 2012,27 ( 11 ) :2231-2237.
  • 5Starup-Linde J, Vestergaard P. Biochemical bone turnover mark- ers in diabetes mellitus - A systematic review[ J]. Bone, 2015. [ Epub ahead of print ].
  • 6Li CI, Liu CS, Lin WY, et al. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Talwan Diabetes Cohort Study [ J ]. J Bone Miner Res, 2015,30 ( 7 ) : 1338 -1346.
  • 7Baggio LL, Dmcker DJ. Biology of incretins: GLP-1 and GIP [J]. Gastroenterology, 2007,132(6) :2131-2157.
  • 8Drucker D J, Yusta B. Physiology and pharmacology of the entero- endocrine hormone glucagon-like peptide-2[ J]. Annu Rev Physi- ol, 2014,76:561-583.
  • 9Henriksen DB, Alexandersen P, Hartmann B, et al. Disassoci- ation of bone resorption and formation by GLP-2 : a 14-day study in healthy postmenopausal women [ J ]. Bone, 2007,40 ( 3 ) : 723 -729.
  • 10Zhong Q, hokawa T, SridharS, et al. Effects of glucosedependent insulinotropie peptide on osteoclast function[J]. Am J Physiol En- docrinol Metab,2007,292 (2) : E543-E548.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部